We are live on ! Find out more
VRM

Vectors Research Management Portfolio holdings

AUM $383M
1-Year Est. Return 30.23%
This Fund
S&P 500
This Quarter Est. Return
+1.99%
1 Year Est. Return
+30.23%
3 Year Est. Return
+67.25%
5 Year Est. Return
+74.92%
10 Year Est. Return
AUM
$204M
AUM Growth
+$18.5M
Cap. Flow
+$165M
Cap. Flow %
81.02%
Top 10 Hldgs %
45.87%
Holding
504
New
64
Increased
82
Reduced
40
Closed
13

Sector Composition

Rank Sector Weight
1 Technology 9.76%
2 Financials 7.43%
3 Consumer Discretionary 3.85%
4 Consumer Staples 3.61%
5 Healthcare 3.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHKP icon
451
Check Point Software Technologies
CHKP
$13B
$1K ﹤0.01%
9
CRON
452
Cronos Group
CRON
$1.06B
$1K ﹤0.01%
75
ECL icon
453
Ecolab
ECL
$78.1B
$1K ﹤0.01%
7
ELAN icon
454
Elanco Animal Health
ELAN
$13.2B
$1K ﹤0.01%
+50
New +$1.5K
FCX icon
455
Freeport-McMoran
FCX
$90B
$1K ﹤0.01%
153
FITB
456
Fifth Third Bancorp
FITB
$51.2B
$1K ﹤0.01%
35
FREL icon
457
Fidelity MSCI Real Estate Index ETF
FREL
$1.5B
$1K ﹤0.01%
+18
New +$489
GAIN icon
458
Gladstone Investment Corp
GAIN
$643M
$1K ﹤0.01%
+100
New +$1.16K
GWW icon
459
W.W. Grainger
GWW
$65.3B
$1K ﹤0.01%
4
JWN
460
DELISTED
Nordstrom
JWN
$1K ﹤0.01%
19
LUMN icon
461
Lumen
LUMN
$6.57B
$1K ﹤0.01%
116
MAR icon
462
Marriott International
MAR
$98.3B
$1K ﹤0.01%
9
NVS icon
463
Novartis
NVS
$297B
$1K ﹤0.01%
16
PRU icon
464
Prudential Financial
PRU
$42.4B
$1K ﹤0.01%
8
REZI icon
465
Resideo Technologies
REZI
$5.19B
$1K ﹤0.01%
53
NYMX
466
DELISTED
Nymox Pharmaceutical Corp
NYMX
$1K ﹤0.01%
500
ADI icon
467
Analog Devices
ADI
$179B
-26
Closed -$3K
AIG icon
468
American International
AIG
$41.7B
$0 ﹤0.01%
8
ALC icon
469
Alcon
ALC
$33.6B
$0 ﹤0.01%
3
ASIX icon
470
AdvanSix
ASIX
$541M
$0 ﹤0.01%
12
BHF icon
471
Brighthouse Financial
BHF
$3.56B
$0 ﹤0.01%
8
CNX icon
472
CNX Resources
CNX
$5.3B
$0 ﹤0.01%
25
FTV icon
473
Fortive
FTV
$17.9B
-282
Closed -$15K
GERN icon
474
Geron
GERN
$828M
$0 ﹤0.01%
100
GGN
475
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$766M
$0 ﹤0.01%
+100
New +$449

Similar funds

Vectors Research Management's Q3 2019 Portfolio in Review

As of Q3 2019, Vectors Research Management held 504 positions worth $204M, up 10% from $185M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Vectors Research Management deployed $165M of net new capital in Q3 2019, opening 64 new positions and adding to 82 existing holdings. Its largest new stake was Iron Mountain: 32,071 shares worth $1.04M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $3M trimmed.

  • Vectors Research Management's largest Q3 2019 buy was Iron Mountain: 32,071 shares worth $1.04M.
  • Vectors Research Management added most to Morgan Stanley in Q3 2019, an estimated $153M increase.
  • Vectors Research Management's biggest Q3 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $3M.
  • Vectors Research Management fully exited AmeriGas Partners, L.P. in Q3 2019, selling an estimated $36K.
  • Vectors Research Management's ten largest holdings make up 46% of its $204M portfolio in Q3 2019.
  • Vectors Research Management opened 64 new positions and closed 13 in Q3 2019.
  • Vectors Research Management's portfolio value rose 10% quarter-over-quarter to $204M.

Based on Vectors Research Management's 13F filing for Q3 2019, filed 15 Nov 2019.